Speaking Up in Support of Federally Funded Research
Factual Footage Inc. is a science consulting firm that specializes in the film & television industries.
FFI consults on all forms of media: film, television, theatre, video games, novels & others
FFI consults on all disciplines of science: biology, chemistry, biochemistry, genetics, physics, medical science
Some of the ways they can help:
Platelet BioGenesis is a biotechnology company that is developing a microfluidic-based bioreactor which mimics human bone marrow to produce human platelets.
July 2, 2014 With the award, approximately $350,000, Thon hopes to produce a next-generation bioreactor to generate the world’s first donor-independent human platelets. The work is expected to scale platelet production to meet global transfusion needs and support drug development by modeling human bone marrow.
April 21, 2014 When you hear about blood shortages, that doesn’t just mean there’s a shortage of donated red blood cells. It could also mean platelets, a blood component that Sven Karlsson described as Band-Aids of the bloodstream, because they’re necessary for blood clot formation to help stop bleeding. Karlsson is a co-founder and chief financial officer of Platelet BioGenesis, a Boston startup that’s developing a way to produce human platelets in a lab using a microfluidic-based bioreactor.
March 27, 2014 One way of boosting platelet production in the lab is with a microfluidic bioreactor that mimics the physical characteristics of megakaryocytes’ bone marrow environment. Unlike traditional static culture methods for growing megakaryocytes, a platelet bioreactor is built to be structurally similar to bone marrow and exposes the cells to the same shear forces they experience within the real bone marrow environment. It also can act as a platform for studying physical and biochemical influences on platelet production.
March 5, 2012 Solving the platelet production problem: A microfluidic device that could reproduce the platelet’s developmental milieu in a way that serves both researchers wanting to understand platelet development and the patients in need of lifesaving platelet transfusions.
Members of ash participate in inaugural advocacy leadership institute.
October 12-13, 2011 The American Society of Hematology (ASH) Government Relations, Practice, and Scientific Affairs department two-day political advocacy program.
December 20, 2010 The American Society of Hematology (ASH) announces the 2011 Scholar Award recipients. The program is designed to support hematologists who have chosen a career in research by providing partial salary or other support during the critical period required for completion of training and achievement of status as an independent investigator.
March 9-10, 2013 The Gordon Research Seminar on Cell Biology of Megakaryocytes and Platelets is a unique forum for graduate students, post-docs, and other scientists with comparable levels of experience and education to present and exchange new data and cutting edge ideas.
The focus of this meeting is to bring together young investigators to present their latest innovative work toward advancing our understanding of megakaryocyte and platelet formation and function. Through career oriented presentations and round table discussion with both academic and pharmaceutical leaders in their field, this GRS will also provide young investigators with valuable career advice from experts conducting basic, translational and pharmaceutical research.
June 3, 2013 Brigham and Women’s Hospital Profile.
June 10, 2013 Democratizing research through crowdfunding as a way to complement federal/private grants for funding basic research.